Governments scramble to develop Ebola drugs

August 13, 2014 6:26 PM

9 0

Governments and drugmakers are scrambling to develop new treatments for the Ebola virus now that the World Health Organization (WHO) has eased restrictions on untested vaccines.

The North Carolina pharmaceutical company in 2013 had received a five-year, $22 million contract from the National Institutes of Health (NIH) to develop the drug but is now being given extra funding to speed up trials.

Also read: Chemical spill at MGP Ingredients reported in Atchison, Kan

Read more

To category page